0
Research Note
Community pharmacist assessment of 10-year risk of coronary heart disease for union workers and their dependents
Yifei Liu, PhD; Leslie J. Mentele, PharmD; Randal P. McDonough, MS, PharmD; Kara M. Carruthers, PharmD; William R. Doucette, PhD
J Am Pharm Assoc (2003) 2008;48:515-517. doi:10.1331/JAPhA.2008.07099

Abstract

Objective  To determine 10-year coronary heart disease (CHD) risk for union workers and their dependents in a pharmacist-managed health screening program.

Methods  Two local unions of plumbers and electricians contracted with a community pharmacy to provide health screening services for union workers and their dependents. Patients chose any one or any combination of three clinical tests: blood pressure, total cholesterol, and HDL cholesterol. At the end of the screening, which took approximately 35 minutes, the participants received brief patient education from pharmacists and a printout of their results. Pharmacists provided the services based on their in-store screening experience and, before the screening, received training on 10-year CHD risk calculation and guidelines regarding cholesterol treatment. Framingham scoring was applied to calculate 10-year CHD risk for participants who chose all three clinical tests.

Results  265 patients (55.8% men, average age 57.7 years) participated in the screening program. Frequency of cardiovascular disease (CVD) risk factors ranged from 25.5% (diastolic blood pressure) to 52.5% (total cholesterol). Using Framingham scoring, 10-year CHD risk was calculated for 226 patients, with 119 (52.7%) patients having less than 10% risk with zero to one CVD risk factor, 73 (32.3%) having 10% to 20% risk with two or more CVD risk factors, and 34 (15%) having greater than 20% risk with two or more risk factors.

Conclusion  Pharmacists provided intermediate- and high-risk participants with guideline-based recommendations such as referring them to physicians for further assessment, therapeutic lifestyle changes, and medication treatment. Community pharmacists were able to identify individuals with intermediate or high 10-year CHD risk. Based on 10-year CHD risk assessment, further pharmacist-managed interventions, such as a cardiovascular risk management program, can be conducted.

Sign In
APhA Members 
Welcome to JAPhA.org! Please log in below using your APhA username and password. Update your APhA profile.
Not a Subscriber
New to JAPhA? Become an APhA member to receive a full subscription to both the print and online editions.

OR

Register for a FREE limited account to benefit from personalization features such as alerts.

References

 American Heart Association. Heart disease and stroke statistics: 2007 update. Dallas, TX:  American Heart Association;  2007.
 
 Centers for Disease Control and Prevention. Preventing heart disease and stroke: addressing the nation's leading killers: at a glance 2005. Accessed at www.cdc.gov/nccdphp/publications/aag/cvh.htm, November 12,  2005.
 
Fullerton HN, Tossi M.Labor force projections to 2010: steady growth and changing composition. In:  Monthly Labor Review.  Washington, DC:  U.S. Department of Labor, Bureau of Labor Statistics; November  2001.
 
Tossi M.Labor force projections to 2012: the graying of the U.S. workforce. In:  Monthly Labor Review, Washington, DC:  U.S. Department of Labor, Bureau of Labor Statistics; February  2004.
 
Sheridan S, Pignone M, Mulrow C. Framingham-based tools to calculate the global risk of coronary heart disease: a systematic review of tools for clinicians.  J Gen Intern Med.  2003;18:1039–52.[PubMed][CrossRef]
 
 National Cholesterol Education Program, National Heart, Lung, and Blood Institute, National Institutes of Health. Detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III) executive summary. Bethesda, MD:  National Institutes of Health;  2001 (NIH publ. no. 01-3670).
 
Blenkinsopp A, Anderson C, Armstrong M. Systematic review of the effectiveness of community pharmacy-based interventions to reduce risk behaviours and risk factors for coronary heart disease.  J Public Health Med.  2003;25:144–53.[PubMed]
 
Snella KA, Canales AE, Irons BK, et al. Pharmacy- and community-based screenings for diabetes and cardiovascular conditions in high risk individuals.  J Am Pharm Assoc.  2006;46:370–7.
 
Ford ES, Giles WH, Mokdad AH.  The distribution of 10-year risk for coronary heart disease among US adults: findings from the National Health and Nutrition Examination Survey III.  J Am Coll Cardiol.  2004;43:1791–6.[PubMed]
 
Ajani UA, Ford ES.  Has the risk for coronary heart disease changed among U.S. adults? J Am Coll Cardiol.  2006;48:1177–82.[PubMed]
 
 Centers for Disease Control and Prevention. Preventing heart disease and stroke. Accessed at www.cdc.gov/nccdphp/publications/factsheets/Prevention/cvh.htm, November 22,  2005.
 
Wilson JB, Osterhaus MC, Farris KB, et al. Financial analysis of cardiovascular wellness program provided to self-insured company from pharmaceutical care provider‘s perspective.  J Am Pharm Assoc.  2006;45:588–92.
 
NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).
Please read the other comments before you post yours. Comments are moderated and will appear on the site at the discertion of the editorial staff.
* = Required Field
(if multiple authors, separate names by comma)
Example: John Doe



Related Content

Customize your page view by dragging & repositioning the boxes below.

JAPhA Articles
Topic Collections
PubMed Articles
Advertisement
 
  • Print
  • PDF Download
  • Email
  • Share
  • Get Citation
  • Submit Comment
  • Article Alerts
    Please Wait... Processing your request... Please Wait.
    You must sign in to sign-up for alerts.

    Please confirm that your email address is correct, so you can successfully receive this alert.

  • Letters To Editor
  • Reprints